SOLANA BEACH, Calif., March 11, 2024 ClearPoint Neuro, Inc. , a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that.
ClearPoint Neuro Stock: Potential Inflection Point (NASDAQ:CLPT) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
ClearPoint Neuro Inc (CLPT) Announces FDA Clearance of the SmartFrame Array V1 1 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
ClearPoint Neuro, Inc. Announces First-in-Human Cases of the SmartFrame Array™ Neuro Navigation System and Software
May 18, 2021 16:05 ET | Source: ClearPoint Neuro, Inc. ClearPoint Neuro, Inc. Irvine, California, UNITED STATES
SOLANA BEACH, Calif., May 18, 2021 (GLOBE NEWSWIRE) ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling company providing navigation and delivery to the brain, today announced the first human cases of the SmartFrame Array Neuro Navigation System and Software. The ‘Array’ system is designed to streamline workflows and reduce procedure time in both the MRI Suite and in the Operating Room. The Company believes the added flexibility of a potential Operating Room placement will allow more hospital sites and surgeons to access ClearPoint’s technology and clinical support.